|
Volumn 18, Issue 2, 2010, Pages 110-112
|
Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma
|
Author keywords
Glaucoma; Lymphoma; Rituximab; Uveitis
|
Indexed keywords
ANTIBIOTIC AGENT;
BRIMONIDINE;
DORZOLAMIDE PLUS TIMOLOL;
LATANOPROST;
LOTEPREDNOL ETABONATE;
LUBRICATING AGENT;
METHYLPREDNISOLONE SODIUM SUCCINATE;
RITUXIMAB;
STEROID;
ADULT;
ARTICLE;
BEDTIME DOSAGE;
CANCER RECURRENCE;
CANCER REGRESSION;
CASE REPORT;
CELL INFILTRATION;
CLINICAL FEATURE;
CONJUNCTIVITIS;
DIAGNOSTIC IMAGING;
DRUG EFFICACY;
DRY EYE;
EYE DISEASE;
FEMALE;
FLOW CYTOMETRY;
GLAUCOMA;
GONIOSCOPY;
HUMAN;
HUMAN TISSUE;
LYMPH NODE BIOPSY;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPHTHALMOLOGY;
ANDROSTADIENES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DRUG THERAPY, COMBINATION;
EYE NEOPLASMS;
FEMALE;
GLAUCOMA;
HUMANS;
LYMPHOMA, B-CELL, MARGINAL ZONE;
MIDDLE AGED;
PAROTID NEOPLASMS;
PROSTAGLANDINS F, SYNTHETIC;
QUINOXALINES;
SULFONAMIDES;
THIOPHENES;
TIMOLOL;
|
EID: 77950581903
PISSN: 09273948
EISSN: 17445078
Source Type: Journal
DOI: 10.3109/09273940903450313 Document Type: Article |
Times cited : (7)
|
References (8)
|